At a glance
- Originator Nonindustrial source
- Class Antibacterials; Antivirals
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Encephalitis virus infections
Most Recent Events
- 21 May 2001 No-Development-Reported for Cancer in Japan (Unknown route)
- 21 May 2001 No-Development-Reported for Encephalitis virus infections in Japan (Unknown route)
- 21 May 1999 Preclinical development for Cancer in Japan (Unknown route)